DK1173766T3 - Isoform af tenascin-C som markör for neoplasier - Google Patents

Isoform af tenascin-C som markör for neoplasier

Info

Publication number
DK1173766T3
DK1173766T3 DK00925224T DK00925224T DK1173766T3 DK 1173766 T3 DK1173766 T3 DK 1173766T3 DK 00925224 T DK00925224 T DK 00925224T DK 00925224 T DK00925224 T DK 00925224T DK 1173766 T3 DK1173766 T3 DK 1173766T3
Authority
DK
Denmark
Prior art keywords
isoform
tenascin
neoplasia
marker
ctn
Prior art date
Application number
DK00925224T
Other languages
English (en)
Inventor
Luciano Zardi
Original Assignee
Philogen Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philogen Spa filed Critical Philogen Spa
Application granted granted Critical
Publication of DK1173766T3 publication Critical patent/DK1173766T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00925224T 1999-04-20 2000-04-19 Isoform af tenascin-C som markör for neoplasier DK1173766T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999FI000094A IT1307864B1 (it) 1999-04-20 1999-04-20 Metodo diagnostico per il riconoscimento di neoplasie umane attraversola determinazione dell'isoforma ctn-c della tn-c, frammenti di
EP00925224A EP1173766B1 (en) 1999-04-20 2000-04-19 A tenascin-c isoform as a marker for neoplasias
PCT/EP2000/003550 WO2000063699A1 (en) 1999-04-20 2000-04-19 A tenascin-c isoform as a marker for neoplasias

Publications (1)

Publication Number Publication Date
DK1173766T3 true DK1173766T3 (da) 2005-01-31

Family

ID=11352932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925224T DK1173766T3 (da) 1999-04-20 2000-04-19 Isoform af tenascin-C som markör for neoplasier

Country Status (11)

Country Link
US (1) US7109301B1 (da)
EP (1) EP1173766B1 (da)
JP (1) JP4577665B2 (da)
AT (1) ATE277352T1 (da)
AU (1) AU779015B2 (da)
CA (1) CA2370666C (da)
DE (1) DE60014064T2 (da)
DK (1) DK1173766T3 (da)
ES (1) ES2226823T3 (da)
IT (1) IT1307864B1 (da)
WO (1) WO2000063699A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317108B1 (it) * 2000-12-06 2003-05-26 Philogen Srl Processo per la selezione di frammenti anticorporali anti-angiogenesi,frammenti anticorpali anti-angiogenesi cosi' ottenuti e loro uso.
CA2446734A1 (en) * 2001-05-24 2002-11-28 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (april)
AU2002365978A1 (en) * 2001-11-19 2003-06-10 Applied Molecular Evolution, Inc. Tumor specific monoclonal antibodies
WO2006050834A2 (en) * 2004-11-09 2006-05-18 Philogen Spa Antibodies against tenascin-c
EP2268608A4 (en) 2008-04-01 2012-01-11 Biosearch Technologies Inc DARK NUCLEIC ACID STABILIZED FLUOROPHORE DEACTIVATOR PROBES
CA2806640A1 (en) 2010-08-13 2012-02-16 Roche Glycart Ag Anti-tenascin-c a2 antibodies and methods of use
WO2017194442A1 (en) 2016-05-11 2017-11-16 F. Hoffmann-La Roche Ag Antigen binding molecules comprising a tnf family ligand trimer and a tenascin binding moiety
CN109071640B (zh) * 2016-05-11 2022-10-18 豪夫迈·罗氏有限公司 经修饰抗生腱蛋白抗体及使用方法
GB201621806D0 (en) 2016-12-21 2017-02-01 Philogen Spa Immunocytokines with progressive activation mechanism
JP7205995B2 (ja) 2017-03-29 2023-01-17 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト 共刺激性ｔｎｆ受容体に対する二重特異性抗原結合分子
CN107058596A (zh) * 2017-06-19 2017-08-18 上海市第十人民医院 一种与恶性胶质瘤诊断相关的标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004464A1 (en) * 1990-09-05 1992-03-19 Wistar Inst Monoclonal antibodies against tenascin
JPH0643167A (ja) * 1992-04-06 1994-02-18 Amano Pharmaceut Co Ltd 癌マーカーであるテネイシン及びその定量法
EP0771216B9 (en) * 1994-07-11 2003-01-02 The Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of tumoral vasculature
EP0781297A4 (en) * 1994-09-16 1999-05-19 Scripps Research Inst CYTOTACTINE DERIVATIVES THAT STIMULATE NEURONAL CONNECTION AND GROWTH OF AXONES AND DENDRITES, THEIR PREPARATION AND USE METHODS
JP3850492B2 (ja) * 1996-08-23 2006-11-29 独立行政法人理化学研究所 テネイシン誘導因子

Also Published As

Publication number Publication date
EP1173766B1 (en) 2004-09-22
JP2002542486A (ja) 2002-12-10
ITFI990094A1 (it) 2000-10-20
DE60014064D1 (de) 2004-10-28
ITFI990094A0 (it) 1999-04-20
IT1307864B1 (it) 2001-11-19
EP1173766A1 (en) 2002-01-23
CA2370666C (en) 2010-06-01
ATE277352T1 (de) 2004-10-15
CA2370666A1 (en) 2000-10-26
DE60014064T2 (de) 2006-02-23
AU4401500A (en) 2000-11-02
WO2000063699A1 (en) 2000-10-26
ES2226823T3 (es) 2005-04-01
JP4577665B2 (ja) 2010-11-10
AU779015B2 (en) 2005-01-06
US7109301B1 (en) 2006-09-19

Similar Documents

Publication Publication Date Title
CY1123400T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1112458T1 (el) Ενα αντισωμα ειδικο για διαλυτο baff για χρηση στην αντιμετωπιση του καρκινου
NO20020554D0 (no) Antistoff-molekyler med spesifisitet for human tumornekrosefaktor-alfa, og anvendelse derav
CR8231A (es) Anticuerpos rg1 y uso de los mismos
ATE432986T1 (de) Menschlicher rezeptor für tumor necrosis factor
AR040748A1 (es) Un metodo y un sistema para posicionar unidades moviles utilizando mediciones de angulo
CY1109468T1 (el) Χρησεις ανταγωνιστων της il-23. σχετικα αντιδραστηρια
MXPA04006517A (es) Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores.
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
BR0115124B1 (pt) dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
ECSP10010653A (es) Anticuerpos anti-il-17a/il-17f de reactividad cruzada y métodos de uso de los mismos
DE602004019812D1 (de) Marker für neuromyelitis optica
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
DK1173766T3 (da) Isoform af tenascin-C som markör for neoplasier
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
ATE439441T1 (de) Veränderte, fluoreszierende proteine
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
CY1106200T1 (el) Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues
AU2017254964B2 (en) Urine markers for detection of bladder cancer
ATE299739T1 (de) Neurokinin b vorläufer aus menschlicher plazenta
DE60116481D1 (de) Molekulargewichtsmarker für western blot
DE60232650D1 (de) Peptiddeformylaseinhibitoren